1932
0
  1. Home
  2. A-Z Publications
  3. Annual Review of Medicine
  4. Volume 60, 2009
  5. Article

Annual Review of Medicine

Volume 60, 2009

Food Allergy: Recent Advances in Pathophysiology and Treatment

Abstract

Food allergies, defined as an adverse immune response to food proteins, affect as many as 6% of young children and 3%–4% of adults in westernized countries, and their prevalence appears to be rising. In addition to well-recognized acute allergic reactions and anaphylaxis triggered by IgE antibody–mediated immune responses to food proteins, there is an increasing recognition of cell-mediated disorders such as eosinophilic gastroenteropathies and food protein–induced enterocolitis syndrome. We are gaining an increasing understanding of the pathophysiology of food allergic disorders and are beginning to comprehend how these result from a failure to establish or maintain normal oral tolerance. Many food allergens have been characterized at a molecular level, and this knowledge, combined with an increasing appreciation of the nature of humoral and cellular immune responses resulting in allergy or tolerance, is leading to novel therapeutic approaches. Currently, management of food allergies consists of educating the patient to avoid ingesting the responsible allergen and initiating therapy if ingestion occurs. However, numerous strategies for definitive treatment are being studied, including sublingual/oral immunotherapy, injection of anti-IgE antibodies, cytokine/anticytokine therapies, Chinese herbal therapies, and novel immunotherapies utilizing engineered proteins and strategic immunomodulators.

Keyword(s): anaphylaxis, food allergens, food hypersensitivity, immunotherapy, oral tolerance
Loading

Article metrics loading...

/content/journals/10.1146/annurev.med.60.042407.205711
2009-02-18
2025-05-18
Loading full text...

Full text loading...

/deliver/fulltext/med/60/1/annurev.med.60.042407.205711.html?itemId=/content/journals/10.1146/annurev.med.60.042407.205711&mimeType=html&fmt=ahah

Literature Cited

  1. Sicherer SH, Sampson HA. 1.  2006. 9. Food allergy. J. Allergy Clin. Immunol. 117:S470–75 [Google Scholar]
  2. Rona RJ, Keil T, Summers C. 2.  et al. 2007. The prevalence of food allergy: a meta-analysis. J. Allergy Clin. Immunol. 120:638–46 [Google Scholar]
  3. Sicherer SH, Munoz-Furlong A, Sampson HA. 3.  2003. Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J. Allergy Clin. Immunol. 112:1203–7 [Google Scholar]
  4. Grundy J, Matthews S, Bateman B. 4.  et al. 2002. Rising prevalence of allergy to peanut in children: data from 2 sequential cohorts. J. Allergy Clin. Immunol. 110:784–89 [Google Scholar]
  5. Hourihane JO, Aiken R, Briggs R. 5.  et al. 2007. The impact of government advice to pregnant mothers regarding peanut avoidance on the prevalence of peanut allergy in United Kingdom children at school entry. J. Allergy Clin. Immunol. 119:1197–202 [Google Scholar]
  6. Chapman JA, Bernstein IL, Lee RE. 6.  et al. 2006. Food allergy: a practice parameter. Ann. Allergy Asthma Immunol. 96:S1–68Comprehensive review and guide for diagnosis and management of IgE-mediated food allergies. [Google Scholar]
  7. Sampson HA. 7.  2001. Utility of food-specific IgE concentrations in predicting symptomatic food allergy. J. Allergy Clin. Immunol. 107:891–96 [Google Scholar]
  8. Astier C, Morisset M, Roitel O. 8.  et al. 2006. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J. Allergy Clin. Immunol. 118:250–56 [Google Scholar]
  9. Flinterman AE, Knol EF, Lencer DA. 9.  et al. 2008. Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J. Allergy Clin. Immunol. 121:737–43 [Google Scholar]
  10. Shreffler WG, Beyer K, Chu TH. 10.  et al. 2004. Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J. Allergy Clin. Immunol. 113:776–82 [Google Scholar]
  11. Vadas P, Gold M, Perelman B. 11.  et al. 2008. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N. Engl. J. Med. 358:28–35 [Google Scholar]
  12. Bock SA, Munoz-Furlong A, Sampson HA. 12.  2007. Further fatalities caused by anaphylactic reactions to food, 2001–2006. J. Allergy Clin. Immunol. 119:1016–18Risk for fatal food allergy is highest for those with asthma, teenagers and young adults, and those who suffer a delay in receiving epinephrine. [Google Scholar]
  13. Steckelbroeck S, Ballmer-Weber BK, Vieths S. 13.  2008. Potential, pitfalls, and prospects of food allergy diagnostics using recombinant allergens or synthetic sequential epitopes. J. Allergy Clin. Immunol. 121:1323–30 [Google Scholar]
  14. Sicherer SH, Furlong TJ, Maes HH. 14.  et al. 2000. Genetics of peanut allergy: a twin study. J. Allergy Clin. Immunol. 106:53–56 [Google Scholar]
  15. Lack G. 15.  2008. Epidemiological risk factors for food allergy. J. Allergy Clin. Immunol. 121:1331–36Review of global environmental issues that may affect food allergy outcomes, including the hygiene hypothesis and the roles of dietary fats and other nutrients that may influence immune function. [Google Scholar]
  16. Fernandez-Rivas M, Bolhaar S, Gonzalez-Mancebo E. 16.  et al. 2006. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J. Allergy Clin. Immunol. 118:481–88 [Google Scholar]
  17. Navuluri L, Parvataneni S, Hassan H. 17.  et al. 2006. Allergic and anaphylactic response to sesame seeds in mice: identification of Ses i 3 and basic subunit of 11s globulins as allergens. Int. Arch. Allergy Immunol. 140:270–76 [Google Scholar]
  18. Strid J, Thomson M, Hourihane J. 18.  et al. 2004. A novel model of sensitization and oral tolerance to peanut protein. Immunology 113:293–303 [Google Scholar]
  19. Lack G, Fox D, Northstone K. 19.  et al. 2003. Factors associated with the development of peanut allergy in childhood. N. Engl. J. Med. 348:977–85 [Google Scholar]
  20. Hill DJ, Hosking CS, de Benedictis FM. 20.  et al. 2008. Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clin. Exp. Allergy 38:161–68 [Google Scholar]
  21. Chehade M, Mayer L. 21.  2005. Oral tolerance and its relation to food hypersensitivities. J. Allergy Clin. Immunol. 115:3–12 [Google Scholar]
  22. Untersmayr E, Jensen-Jarolim E. 22.  2008. The role of protein digestibility and antacids on food allergy outcomes. J. Allergy Clin. Immunol. 121:1301–8 [Google Scholar]
  23. Mowat AM. 23.  2003. Anatomical basis of tolerance and immunity to intestinal antigens. Nat. Rev. Immunol. 3:331–41 [Google Scholar]
  24. Strobel S, Mowat AM. 24.  2006. Oral tolerance and allergic responses to food proteins. Curr. Opin. Allergy Clin. Immunol. 6:207–13 [Google Scholar]
  25. Frossard CP, Tropia L, Hauser C. 25.  et al. 2004. Lymphocytes in Peyer patches regulate clinical tolerance in a murine model of food allergy. J. Allergy Clin. Immunol. 113:958–64 [Google Scholar]
  26. St Clair EW, Turka LA, Saxon A. 26.  et al. 2007. New reagents on the horizon for immune tolerance. Annu. Rev. Med. 58:329–46 [Google Scholar]
  27. Sudo N, Sawamura S, Tanaka K. 27.  et al. 1997. The requirement of intestinal bacterial flora for the development of an IgE production system fully susceptible to oral tolerance induction. J. Immunol. 159:1739–45 [Google Scholar]
  28. Bashir ME, Louie S, Shi HN. 28.  et al. 2004. Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol. 172:6978–87Dissects the role of stimulation of immune receptors that regulate innate immunity in a murine model, revealing their role in avoiding allergic sensitization. Provides mechanistic data supporting the hygiene hypothesis and the means of strategizing prevention and treatment approaches. [Google Scholar]
  29. Prescott SL, Bjorksten B. 29.  2007. Probiotics for the prevention or treatment of allergic diseases. J. Allergy Clin. Immunol. 120:255–62 [Google Scholar]
  30. Torgerson TR, Ochs HD. 30.  2007. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J. Allergy Clin. Immunol. 120:744–50 [Google Scholar]
  31. Karlsson MR, Rugtveit J, Brandtzaeg P. 31.  2004. Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy. J. Exp. Med. 199:1679–88 [Google Scholar]
  32. van Wijk F, Wehrens EJ, Nierkens S. 32.  et al. 2007. CD4+CD25+ T cells regulate the intensity of hypersensitivity responses to peanut, but are not decisive in the induction of oral sensitization. Clin. Exp. Allergy 37:572–81 [Google Scholar]
  33. Blazquez AB, Berin MC. 33.  2008. Gastrointestinal dendritic cells promote Th2 skewing via OX40L. J. Immunol. 180:4441–50 [Google Scholar]
  34. Yang PC, Xing Z, Berin CM. 34.  et al. 2007. TIM-4 expressed by mucosal dendritic cells plays a critical role in food antigen-specific Th2 differentiation and intestinal allergy. Gastroenterologica 133:1522–33 [Google Scholar]
  35. Turcanu V, Maleki SJ, Lack G. 35.  2003. Characterization of lymphocyte responses to peanuts in normal children, peanut-allergic children, and allergic children who acquired tolerance to peanuts. J. Clin. Invest. 111:1065–72 [Google Scholar]
  36. Thottingal TB, Stefura BP, Simons FE. 36.  et al. 2006. Human subjects without peanut allergy demonstrate T cell–dependent, TH2-biased, peanut-specific cytokine and chemokine responses independent of TH1 expression. J. Allergy Clin. Immunol. 118:905–14 [Google Scholar]
  37. Abernathy-Carver K, Sampson H, Picker L. 37.  et al. 1995. Milk-induced eczema is associated with the expansion of T cells expressing cutaneous lymphocyte antigen. J. Clin. Invest. 95:913–18 [Google Scholar]
  38. Reekers R, Busche M, Wittmann M. 38.  et al. 1999. Birch pollen–related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J. Allergy Clin. Immunol. 104:466–72 [Google Scholar]
  39. Bohle B, Zwolfer B, Heratizadeh A. 39.  et al. 2006. Cooking birch pollen–related food: divergent consequences for IgE- and T cell–mediated reactivity in vitro and in vivo. J. Allergy Clin. Immunol. 118:242–49 [Google Scholar]
  40. Sampson HA. 40.  1999. Food allergy. Part 1: Immunopathogenesis and clinical disorders. J. Allergy Clin. Immunol. 103:717–28 [Google Scholar]
  41. Knight AK, Blazquez AB, Zhang S. 41.  et al. 2007. CD4 T cells activated in the mesenteric lymph node mediate gastrointestinal food allergy in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G1234–43 [Google Scholar]
  42. Eigenmann PA, Tropia L, Hauser C. 42.  1999. The mucosal adhesion receptor alpha4beta7 integrin is selectively increased in lymphocytes stimulated with beta-lactoglobulin in children allergic to cow's milk. J. Allergy Clin. Immunol. 103:931–36 [Google Scholar]
  43. Benlounes N, Candalh C, Matarazzo P. 43.  et al. 1999. The time-course of milk antigen-induced TNF-alpha secretion differs according to the clinical symptoms in children with cow's milk allergy. J. Allergy Clin. Immunol. 104:863–69 [Google Scholar]
  44. Chung HL, Hwang JB, Park JJ. 44.  et al. 2002. Expression of transforming growth factor beta1, transforming growth factor type I and II receptors, and TNF-alpha in the mucosa of the small intestine in infants with food protein-induced enterocolitis syndrome. J. Allergy Clin. Immunol. 109:150–54 [Google Scholar]
  45. Furuta GT, Liacouras CA, Collins MH. 45.  et al. 2007. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterologica 133:1342–63Comprehensive review and consensus report on diagnosis and management of an emerging disease, eosinophilic esophagitis. [Google Scholar]
  46. Liacouras CA, Spergel JM, Ruchelli E. 46.  et al. 2005. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol. 3:1198–206 [Google Scholar]
  47. Blanchard C, Wang N, Stringer KF. 47.  et al. 2006. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 116:536–47 [Google Scholar]
  48. Blanchard C, Mingler MK, Vicario M. 48.  et al. 2007. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J. Allergy Clin. Immunol. 120:1292–300 [Google Scholar]
  49. Radauer C, Breiteneder H. 49.  2007. Evolutionary biology of plant food allergens. J. Allergy Clin. Immunol. 120:518–25 [Google Scholar]
  50. Jenkins JA, Breiteneder H, Mills EN. 50.  2007. Evolutionary distance from human homologs reflects allergenicity of animal food proteins. J. Allergy Clin. Immunol. 120:1399–405 [Google Scholar]
  51. Sicherer SH, Sampson HA. 51.  2007. Peanut allergy: emerging concepts and approaches for an apparent epidemic. J. Allergy Clin. Immunol. 120:491–503 [Google Scholar]
  52. Maleki SJ, Viquez O, Jacks T. 52.  et al. 2003. The major peanut allergen, Ara h 2, functions as a trypsin inhibitor, and roasting enhances this function. J. Allergy Clin. Immunol. 112:190–95 [Google Scholar]
  53. Beyer K, Morrow E, Li XM. 53.  et al. 2001. Effects of cooking methods on peanut allergenicity. J. Allergy Clin. Immunol. 107:1077–81 [Google Scholar]
  54. Shreffler WG, Castro RR, Kucuk ZY. 54.  et al. 2006. The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell–specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J. Immunol. 177:3677–85 [Google Scholar]
  55. Meyer S, van Liempt E, Imberty A. 55.  et al. 2005. DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. J. Biol. Chem. 280:37349–59 [Google Scholar]
  56. Stanley JS, King N, Burks AW. 56.  et al. 1997. Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch. Biochem. Biophys. 342:244–53 [Google Scholar]
  57. 57. Joint Task Force on Practice Parameters: American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology 2007. Allergen immunotherapy: a practice parameter second update. J. Allergy Clin. Immunol. 120:S25–85 [Google Scholar]
  58. Bolhaar ST, Tiemessen MM, Zuidmeer L. 58.  et al. 2004. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin. Exp. Allergy 34:761–69 [Google Scholar]
  59. Nelson HS, Lahr J, Rule R. 59.  et al. 1997. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J. Allergy Clin. Immunol. 99:744–51 [Google Scholar]
  60. Bohle B, Kinaciyan T, Gerstmayr M. 60.  et al. 2007. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J. Allergy Clin. Immunol. 120:707–13 [Google Scholar]
  61. Enrique E, Pineda F, Malek T. 61.  et al. 2005. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J. Allergy Clin. Immunol. 116:1073–79 [Google Scholar]
  62. De Boissieu D, Dupont C. 62.  2006. Sublingual immunotherapy for cow's milk protein allergy: a preliminary report. Allergy 61:1238–39 [Google Scholar]
  63. Patriarca G, Nucera E, Roncallo C. 63.  et al. 2003. Oral desensitizing treatment in food allergy: clinical and immunological results. Aliment. Pharmacol. Ther. 17:459–65 [Google Scholar]
  64. Meglio P, Bartone E, Plantamura M. 64.  et al. 2004. A protocol for oral desensitization in children with IgE-mediated cow's milk allergy. Allergy 59:980–87 [Google Scholar]
  65. Morisset M, Moneret-Vautrin DA, Guenard L. 65.  et al. 2007. Oral desensitization in children with milk and egg allergies obtains recovery in a significant proportion of cases. A randomized study in 60 children with cow's milk allergy and 90 children with egg allergy. Eur. Ann. Allergy Clin. Immunol. 39:12–19 [Google Scholar]
  66. Staden U, Rolinck-Werninghaus C, Brewe F. 66.  et al. 2007. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Allergy 62:1261–69First oral-immunotherapy study to carefully follow a large group of treated and untreated participants. Raises concerns regarding lack of oral tolerance induction. [Google Scholar]
  67. Longo G, Barbi E, Berti I. 67.  et al. 2007. Specific oral tolerance induction in children with very severe cow's milk-induced reactions. J. Allergy Clin. Immunol. 121:343–47 [Google Scholar]
  68. Buchanan AD, Green TD, Jones SM. 68.  et al. 2007. Egg oral immunotherapy in nonanaphylactic children with egg allergy. J. Allergy Clin. Immunol. 119:199–205 [Google Scholar]
  69. Bannon GA, Cockrell G, Connaughton C. 69.  et al. 2001. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy. Int. Arch. Allergy Immunol. 124:70–72 [Google Scholar]
  70. Rabjohn P, Helm EM, Stanley JS. 70.  et al. 1999. Molecular cloning and epitope analysis of the peanut allergen Ara h 3. J. Clin. Invest. 103:535–42 [Google Scholar]
  71. Swoboda I, Bugajska-Schretter A, Linhart B. 71.  et al. 2007. A recombinant hypoallergenic parvalbumin mutant for immunotherapy of IgE-mediated fish allergy. J. Immunol. 178:6290–96 [Google Scholar]
  72. Ma Y, Gadermaier G, Bohle B. 72.  et al. 2006. Mutational analysis of amino acid positions crucial for IgE-binding epitopes of the major apple (Malus domestica) allergen, Mal d 1. Int. Arch. Allergy Immunol. 139:53–62 [Google Scholar]
  73. Li XM, Srivastava K, Grishin A. 73.  et al. 2003. Persistent protective effect of heat-killed Escherichia coli producing “engineered,” recombinant peanut proteins in a murine model of peanut allergy. J. Allergy Clin. Immunol. 112:159–67Preclinical study of an engineered immunotherapeutic vaccine soon to enter clinical trials. [Google Scholar]
  74. Nowak-Wegrzyn A, Sampson HA. 74.  2004. Food allergy therapy. Immunol. Allergy Clin. North Am. 24:705–25 [Google Scholar]
  75. Li S, Li XM, Burks AW. 74a.  et al. 2001. Modulation of peanut allergy by peptide-based immunotherapy. J. Allergy Clin. Immunol. 107:S233 (Abstr.) [Google Scholar]
  76. Roy K, Mao HQ, Huang SK. 75.  et al. 1999. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med. 5:387–91 [Google Scholar]
  77. Li X, Huang CK, Schofield BH. 76.  et al. 1999. Strain-dependent induction of allergic sensitization caused by peanut allergen DNA immunization in mice. J. Immunol. 162:3045–52 [Google Scholar]
  78. Kattan JD, Srivastava KD, Li XM, Sampson HA. 76a.  2003. Intranasal treatment with CpG oligonucleotides provides protection from anaphylaxis in a murine model of peanut allergy. J. Allergy Clin. Immunol. 111:S206 (Abstr.) [Google Scholar]
  79. Nguyen MD, Cinman N, Yen J. 77.  et al. 2001. DNA-based vaccination for the treatment of food allergy. Allergy 56:Suppl. 67127–30 [Google Scholar]
  80. Leung DY, Sampson HA, Yunginger JW. 78.  et al. 2003. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 348:986–93First large clinical trial of a treatment for food allergy. Anti-IgE shows promise in raising the threshold of reactivity but not all participants were protected. [Google Scholar]
  81. Sampson HA, Leung DYM, Burks AW. 79.  et al. 2007. A phase II, randomized, double-blind, parallel group, placebo-controlled, oral food challenge trial of Xolair® (omalizumab) in peanut allergy (TOPS). J. Allergy Clin. Immun. 119:1S117 (Abstr.) [Google Scholar]
  82. Foroughi S, Foster B, Kim N. 80.  et al. 2007. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J. Allergy Clin. Immunol. 120:594–601 [Google Scholar]
  83. Srivastava KD, Kattan JD, Zou ZM. 81.  et al. 2005. The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J. Allergy Clin. Immunol. 115:171–78This Chinese herbal medicine was completely effective in treating peanut allergy in a murine model of peanut anaphylaxis. [Google Scholar]
  84. Li XM.82.  2007. Traditional Chinese herbal remedies for asthma and food allergy. J. Allergy Clin. Immunol. 120:25–31 [Google Scholar]
  85. Frossard CP, Steidler L, Eigenmann PA. 83.  2007. Oral administration of an IL-10-secreting Lactococcus lactis strain prevents food-induced IgE sensitization. J. Allergy Clin. Immunol. 119:952–59 [Google Scholar]
  86. Ando T, Hatsushika K, Wako M. 84.  et al. 2007. Orally administered TGF-beta is biologically active in the intestinal mucosa and enhances oral tolerance. J. Allergy Clin. Immunol. 120:916–23 [Google Scholar]
  87. Stein ML, Collins MH, Villanueva JM. 85.  et al. 2006. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J. Allergy Clin. Immunol. 118:1312–19 [Google Scholar]
  88. Frick OL, Teuber SS, Buchanan BB. 86.  et al. 2005. Allergen immunotherapy with heat-killed Listeria monocytogenes alleviates peanut and food-induced anaphylaxis in dogs. Allergy 60:243–50 [Google Scholar]
  89. Li XM, Srivastava K, Huleatt JW. 87.  et al. 2003. Engineered recombinant peanut protein and heat-killed Listeria monocytogenes coadministration protects against peanut-induced anaphylaxis in a murine model. J. Immunol. 170:3289–95 [Google Scholar]
  90. Zhu FG, Kandimalla ER, Yu D. 88.  et al. 2007. Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in mice. J. Allergy Clin. Immunol. 120:631–37 [Google Scholar]
  91. Creticos PS, Schroeder JT, Hamilton RG. 89.  et al. 2006. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N. Engl. J. Med. 355:1445–55 [Google Scholar]
  92. Saxon A, Kepley C, Zhang K. 90.  2008. “Accentuate the negative, eliminate the positive”: engineering allergy therapeutics to block allergic reactivity through negative signaling. J. Allergy Clin. Immunol. 121:320–25 [Google Scholar]
/content/journals/10.1146/annurev.med.60.042407.205711
Loading
Food Allergy: Recent Advances in Pathophysiology and Treatment
Annual Review of Medicine 60, 261 (2009); https://doi.org/10.1146/annurev.med.60.042407.205711
/content/journals/10.1146/annurev.med.60.042407.205711
/content/journals/10.1146/annurev.med.60.042407.205711
Loading

Data & Media loading...

  • Article Type: Review Article

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error